Literature DB >> 10784068

Volume and differentiation of striatal grafts in rats: relationship to the number of cells implanted.

C Watts1, I R McNamara, S B Dunnett.   

Abstract

A growing body of evidence suggests that graft-mediated functional recovery in animal models of Huntington's disease is influenced by the morphology of the striatal grafts. Various parameters, including embryonic dissection, tissue preparation, and surgical delivery into the brain, have been investigated with the aim of increasing the proportion of the grafts comprising striatum-like tissue. While growing evidence suggests that implants derived from the selective dissection of the lateral ganglionic eminence (LGE) contain more striatal tissue, the relationship between the quantity of LGE tissue implanted and the striatum-like proportion of the resultant grafts has not been formally investigated. In this study the volume of striatum-like tissue within the grafts did not increase in a linear manner with increasing numbers of cells implanted. The proportion of the grafts that comprised the striatum-like patch compartment or P-zone remained constant after an initial rapid increase as the number of LGE cells implanted was increased. These results have important practical implications in determining the optimum number of LGE cells to implant and hence in the design of any surgical protocol for the clinical application of this technique.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10784068     DOI: 10.1177/096368970000900109

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  6 in total

Review 1.  Mesenchymal stem cells for the treatment of neurodegenerative disease.

Authors:  Nanette Joyce; Geralyn Annett; Louisa Wirthlin; Scott Olson; Gerhard Bauer; Jan A Nolta
Journal:  Regen Med       Date:  2010-11       Impact factor: 3.806

2.  Implantation of undifferentiated and pre-differentiated human neural stem cells in the R6/2 transgenic mouse model of Huntington's disease.

Authors:  Gehan El-Akabawy; Ivan Rattray; Saga M Johansson; Richard Gale; Gillian Bates; Michel Modo
Journal:  BMC Neurosci       Date:  2012-08-09       Impact factor: 3.288

3.  The Current Status of Neural Grafting in the Treatment of Huntington's Disease. A Review.

Authors:  Ruwani Wijeyekoon; Roger A Barker
Journal:  Front Integr Neurosci       Date:  2011-12-07

Review 4.  Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease.

Authors:  Scott D Olson; Kari Pollock; Amal Kambal; Whitney Cary; Gaela-Marie Mitchell; Jeremy Tempkin; Heather Stewart; Jeannine McGee; Gerhard Bauer; Hyun Sook Kim; Teresa Tempkin; Vicki Wheelock; Geralyn Annett; Gary Dunbar; Jan A Nolta
Journal:  Mol Neurobiol       Date:  2011-12-09       Impact factor: 5.590

Review 5.  Differentiation of pluripotent stem cells into striatal projection neurons: a pure MSN fate may not be sufficient.

Authors:  Amy E Reddington; Anne E Rosser; Stephen B Dunnett
Journal:  Front Cell Neurosci       Date:  2014-12-02       Impact factor: 5.505

6.  The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease.

Authors:  Roger A Barker; Sarah L Mason; Timothy P Harrower; Rachel A Swain; Aileen K Ho; Barbara J Sahakian; Raj Mathur; Sohier Elneil; Steven Thornton; Carrie Hurrelbrink; Richard J Armstrong; Pam Tyers; Emma Smith; Adrian Carpenter; Paola Piccini; Yen F Tai; David J Brooks; Nicola Pavese; Colin Watts; John D Pickard; Anne E Rosser; Stephen B Dunnett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-01-23       Impact factor: 10.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.